U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07222709) titled 'A Study to Assess the Adverse Events and How Oral ABBV-1042 Moves Through the Body of Healthy Adult Participants' on Oct. 29.
Brief Summary: This study will assess the adverse events, tolerability, and how oral ascending doses of ABBV-1042 moves through the body of healthy adult participants.
Study Start Date: Oct. 27
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteer
Intervention:
DRUG: ABBV-1042
Oral Solution
DRUG: Placebo
Oral Solution
Recruitment Status: RECRUITING
Sponsor: AbbVie
Published by HT Digital Content Services with permission from Health Daily Digest....